Dr. Shelia Takamura, a young, dedicated oncologist, is proud to be involved in the clinical trials. Once the FDA approves it for widespread use, VG723 will revolutionize cancer therapy. That is why she's alarmed when former patients return with bizarre syndromes. Yes, they're cancer free, but they're experiencing dramatic changes in their hair and skin and general appearance. When she investigates a possible link to the protocol, those patients start dying. As the body count grows, Shelia finds her own life in danger. She comes to suspect there might be a literal meaning behind the Tethys motto—"Changing the world. One person at a time..."